Latest filing published 23 Apr 2026 for Bio-Rad Laboratories, INC..
Filing timeline
BuySaleInsider track record
Jeffrey L. Edwards: trading record in brief
Jeffrey L. Edwards (board member) discloses dealings in 4 companies, chiefly Allergan Inc, Kyntra Bio, Inc. and Lifecore Biomedical, Inc. \DE\. The record holds 94 filings, for trades running from 6 February 2006 to 21 April 2026.
No open-market purchase appears, only 46 sales worth €47.9M. Besides market trades, the filings include 22 share grants and 25 option exercises.
The record was last updated on 23 April 2026 with an option exercise in Bio-Rad Laboratories, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jeffrey L. Edwards
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 407 shares0Bio-Rad A Common StockSEC:0001190642-26-000002:0
- 308 shares0Bio-Rad A Common StockSEC:0001062993-25-007905:0
- 30,000 sharesCommon StockSEC:0001628280-24-031630:0
- 9,554 sharesCommon StockSEC:0001628280-24-003134:0
- 3,265 shares@ US$16.7440.3% of flowCommon StockSEC:0001209191-23-036076:1
- 4,624 shares@ US$17.5159.7% of flowCommon StockSEC:0001209191-23-036076:2
- 8,289 shares0Common StockSEC:0001209191-23-036076:0
- 18,182 sharesCommon StockSEC:0001628280-23-020831:0
- 9,474 sharesCommon StockSEC:0001628280-23-020580:0
- 15,777 shares0Common StockSEC:0001209191-22-038609:0
- 7,059 shares@ US$9.5057.8% of flowCommon StockSEC:0001628280-22-016486:0
- 5,398 shares@ US$9.7742.2% of flowCommon StockSEC:0001593968-21-002278:0
- 4,700 shares0Common StockSEC:0001209191-21-036675:0
- 4,700 shares0Common StockSEC:0001209191-20-035147:0
- 4,700 shares0Common StockSEC:0001209191-19-035650:0
- 3,700 shares0Common StockSEC:0001209191-18-036509:0
- 38,900 shares@ US$40.16Common StockSEC:0001127602-14-007716:0
- 38,900 shares@ US$126.39Common StockSEC:0001127602-14-007716:1
- 280 shares@ US$124.57Common StockSEC:0001127602-14-007041:0
- 105,500 shares@ US$64.47Common StockSEC:0001127602-14-005705:0
- 105,500 shares@ US$117.74Common StockSEC:0001127602-14-005705:1
- 29,200 shares@ US$58.55Common StockSEC:0001127602-13-024760:0
- 29,200 shares@ US$91.32Common StockSEC:0001127602-13-024760:1
- 40,000 shares@ US$40.16Common StockSEC:0001127602-13-024760:2
- 40,000 shares@ US$91.05Common StockSEC:0001127602-13-024760:3
25 of 94 declarations
